RedHill Biopharma (RDHL) EBITDA Margin Growth (1y) (2013 - 2023)
Powered by 
Analysis
RedHill Biopharma (RDHL) EBITDA Margin Growth (1y) (2013 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -1,647.00 |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -634.00 |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -1,576.00 |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 93.00 |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 840.00 |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 864.00 |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -12,485.00 |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | -258.00 |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 3,802.00 |
| 10 | RedHill Biopharma | 10.63 Mn | 10.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 294,295.00 |
| Mar 31, 2023 | -93,490.00 |
| Dec 31, 2022 | 4,962.00 |
| Sep 30, 2022 | -4,002.00 |
| Jun 30, 2022 | -6,581.00 |
| Mar 31, 2022 | 3,868.00 |
| Dec 31, 2021 | -73,327.00 |
| Sep 30, 2021 | 1,147.00 |
| Jun 30, 2021 | 5,593.00 |
| Mar 31, 2021 | -152,314.00 |
| Dec 31, 2020 | -64,804.00 |
| Sep 30, 2020 | -63,360.00 |
| Jun 30, 2020 | -73,226.00 |
| Mar 31, 2020 | 108,097.00 |
| Dec 31, 2019 | 87.00 |
| Sep 30, 2019 | 26,130.00 |
| Jun 30, 2019 | 38,539.00 |
| Mar 31, 2019 | 12,160.00 |
| Dec 31, 2018 | 2,106.00 |
| Sep 30, 2018 | -47,560.00 |